Neuraxis, Inc. Files Q1 2025 10-Q

Ticker: NRXS · Form: 10-Q · Filed: May 12, 2025 · CIK: 1933567

Neuraxis, INC 10-Q Filing Summary
FieldDetail
CompanyNeuraxis, INC (NRXS)
Form Type10-Q
Filed DateMay 12, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

Neuraxis Q1 2025 10-Q filed. Financials out.

AI Summary

Neuraxis, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance sheet items and statements of operations. The company is based in Carmel, Indiana, and operates in the electromedical and electrotherapeutic apparatus industry.

Why It Matters

This filing provides investors with the latest financial performance and position of Neuraxis, Inc. for the first quarter of 2025, crucial for understanding the company's ongoing operations and future prospects.

Risk Assessment

Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new disclosures that would indicate a high-risk event.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Neuraxis, Inc.?

Neuraxis, Inc. operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, with SIC code 3845.

What is the Central Index Key (CIK) for Neuraxis, Inc.?

The CIK for Neuraxis, Inc. is 0001933567.

What is the SEC file number for Neuraxis, Inc.?

The SEC file number for Neuraxis, Inc. is 001-41775.

Where is Neuraxis, Inc. located?

Neuraxis, Inc. is located in Carmel, IN, with a ZIP code of 46032.

What period does this 10-Q filing cover?

This 10-Q filing covers the period ending March 31, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Neuraxis, INC (NRXS).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing